These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 20876284
21. S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. Ray S, Shyam S, Fraizer GC, Almasan A. Mol Cancer Ther; 2007 Apr; 6(4):1368-78. PubMed ID: 17431115 [Abstract] [Full Text] [Related]
22. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes. Wachter T, Sprick M, Hausmann D, Kerstan A, McPherson K, Stassi G, Bröcker EB, Walczak H, Leverkus M. J Biol Chem; 2004 Dec 17; 279(51):52824-34. PubMed ID: 15459191 [Abstract] [Full Text] [Related]
23. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. Kavuri SM, Geserick P, Berg D, Dimitrova DP, Feoktistova M, Siegmund D, Gollnick H, Neumann M, Wajant H, Leverkus M. J Biol Chem; 2011 May 13; 286(19):16631-46. PubMed ID: 21454681 [Abstract] [Full Text] [Related]
24. Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death. Tian B, Yang Q, Mao Z. Nat Cell Biol; 2009 Feb 13; 11(2):211-8. PubMed ID: 19151707 [Abstract] [Full Text] [Related]
25. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL. French R, Hayward O, Jones S, Yang W, Clarkson R. Mol Cancer; 2015 Dec 15; 14():209. PubMed ID: 26667821 [Abstract] [Full Text] [Related]
26. Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation. Sophonnithiprasert T, Nilwarangkoon S, Nakamura Y, Watanapokasin R. Int J Oncol; 2015 Dec 15; 47(6):2188-96. PubMed ID: 26499766 [Abstract] [Full Text] [Related]
27. Induction of p53 renders ATM-deficient mice refractory to hepatocarcinogenesis. Teoh N, Pyakurel P, Dan YY, Swisshelm K, Hou J, Mitchell C, Fausto N, Gu Y, Farrell G. Gastroenterology; 2010 Mar 15; 138(3):1155-65.e1-2. PubMed ID: 19919837 [Abstract] [Full Text] [Related]
28. FOXO3 signalling links ATM to the p53 apoptotic pathway following DNA damage. Chung YM, Park SH, Tsai WB, Wang SY, Ikeda MA, Berek JS, Chen DJ, Hu MC. Nat Commun; 2012 Mar 15; 3():1000. PubMed ID: 22893124 [Abstract] [Full Text] [Related]
29. Dissection of cell context-dependent interactions between HBx and p53 family members in regulation of apoptosis: a role for HBV-induced HCC. Knoll S, Fürst K, Thomas S, Villanueva Baselga S, Stoll A, Schaefer S, Pützer BM. Cell Cycle; 2011 Oct 15; 10(20):3554-65. PubMed ID: 22030623 [Abstract] [Full Text] [Related]
30. Quercetin sensitizes pancreatic cancer cells to TRAIL-induced apoptosis through JNK-mediated cFLIP turnover. Kim JH, Kim MJ, Choi KC, Son J. Int J Biochem Cell Biol; 2016 Sep 15; 78():327-334. PubMed ID: 27477310 [Abstract] [Full Text] [Related]
31. Phosphorylated Hsp27 activates ATM-dependent p53 signaling and mediates the resistance of MCF-7 cells to doxorubicin-induced apoptosis. Xu Y, Diao Y, Qi S, Pan X, Wang Q, Xin Y, Cao X, Ruan J, Zhao Z, Luo L, Liu C, Yin Z. Cell Signal; 2013 May 15; 25(5):1176-85. PubMed ID: 23357534 [Abstract] [Full Text] [Related]
32. A positive role for c-Abl in Atm and Atr activation in DNA damage response. Wang X, Zeng L, Wang J, Chau JF, Lai KP, Jia D, Poonepalli A, Hande MP, Liu H, He G, He L, Li B. Cell Death Differ; 2011 Jan 15; 18(1):5-15. PubMed ID: 20798688 [Abstract] [Full Text] [Related]
33. P38MAPK is a major determinant of the balance between apoptosis and autophagy triggered by 5-fluorouracil: implication in resistance. de la Cruz-Morcillo MA, Valero ML, Callejas-Valera JL, Arias-González L, Melgar-Rojas P, Galán-Moya EM, García-Gil E, García-Cano J, Sánchez-Prieto R. Oncogene; 2012 Mar 01; 31(9):1073-85. PubMed ID: 21841826 [Abstract] [Full Text] [Related]
34. Partial contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)/TRAIL receptor pathway to antitumor effects of interferon-alpha/5-fluorouracil against Hepatocellular Carcinoma. Yamamoto T, Nagano H, Sakon M, Wada H, Eguchi H, Kondo M, Damdinsuren B, Ota H, Nakamura M, Wada H, Marubashi S, Miyamoto A, Dono K, Umeshita K, Nakamori S, Yagita H, Monden M. Clin Cancer Res; 2004 Dec 01; 10(23):7884-95. PubMed ID: 15585621 [Abstract] [Full Text] [Related]
35. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalik TF, Jung JU. J Virol; 2006 Mar 01; 80(5):2257-66. PubMed ID: 16474133 [Abstract] [Full Text] [Related]
36. Wogonin and related natural flavones overcome tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) protein resistance of tumors by down-regulation of c-FLIP protein and up-regulation of TRAIL receptor 2 expression. Ding J, Polier G, Köhler R, Giaisi M, Krammer PH, Li-Weber M. J Biol Chem; 2012 Jan 02; 287(1):641-649. PubMed ID: 22086925 [Abstract] [Full Text] [Related]
37. Inhibition of methyltransferases accelerates degradation of cFLIP and sensitizes B-cell lymphoma cells to TRAIL-induced apoptosis. Braun FK, Mathur R, Sehgal L, Wilkie-Grantham R, Chandra J, Berkova Z, Samaniego F. PLoS One; 2015 Jan 02; 10(3):e0117994. PubMed ID: 25738497 [Abstract] [Full Text] [Related]
38. Down-regulation of cFLIP following reovirus infection sensitizes human ovarian cancer cells to TRAIL-induced apoptosis. Clarke P, Tyler KL. Apoptosis; 2007 Jan 02; 12(1):211-23. PubMed ID: 17136319 [Abstract] [Full Text] [Related]
39. Death receptor-induced activation of the Chk2- and histone H2AX-associated DNA damage response pathways. Solier S, Sordet O, Kohn KW, Pommier Y. Mol Cell Biol; 2009 Jan 02; 29(1):68-82. PubMed ID: 18955500 [Abstract] [Full Text] [Related]
40. Low-dose 5-fluorouracil sensitizes HepG2 cells to TRAIL through TRAIL receptor DR5 and survivin-dependent mechanisms. Yang L, Wang Y, Zheng H, Zhang D, Wu X, Sun G, Yang T. J Chemother; 2017 Jun 02; 29(3):179-188. PubMed ID: 28067150 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]